
Milena Schönke
@milenaschonke
Assistant Professor in metabolism @LUMC_Leiden #exercise #atherosclerosis #diabetes #masld #circadianrhythms #microbiota
ID: 1049674409546526721
09-10-2018 14:54:16
665 Tweet
556 Followers
425 Following

Latest paper from Patrick Rensen showing the advantage of GIPR/GLP1R dual agonism in the treatment of cardiovascular disease. Work by twitterless Robin van Eenige with @KooijmanSander and in collaboration with Guigas lab.

...and the proudest co-promotor! Dr. Wietse In het Panhuis, you are a shining example of perseverance, critical thinking and collegiality! We will miss you LUMC Leiden


Today Cong Liu defended her beautiful PhD thesis (inside and out!) LUMC Leiden. Happy new doctor and happy (co)promotors! Good luck in New York The Tisch Cancer Institute, Cong, you'll without a doubt continue to do great there!


Great first day of the DTMC with many new and "old" faces, nice talks and a live music quiz! Was told by Riekelt Houtkooper that I am not junior anymore...a compliment?


Happy to share our latest work from LUMC Leiden on the effect of exercise at different times of day on liver health. Surprisingly, we found particularly early exercise training to promote the influx of pro-inflammatory cells into mildly fatty livers. xiahepublishing.com/2310-8819/JCTH…



If I had to choose a theme song for this year's Danish Diabetes and Endocrine Academy Postdoc Summit it would be "You'll never walk alone". Sharing career considerations, hopes and frustrations with others in the same boat is priceless. Thanks organizers and funders for hosting this great event!


Milena Schönke about the study done in collaboration between Lipigon Pharmaceuticals and LUMC Leiden. Great work and great results in favor for targeting ANGPTL4. #Lipisense lipigon.se/hoega-blodfett…



New research on mice suggests that a simple #lifestyle change – changing mealtimes – could alleviate the negative effects of shift #work on the circulatory system. #sciencenewsdk Milena Schönke sciencenews.dk/en/intermitten…

Latest from the team: When the last step of the cholesterol synthesis pathway is inhibited, liver lipids and the number of circulating monocytes decrease - but atherosclerosis development is not slowed down. cell.com/iscience/fullt… LUMC Leiden Patrick Rensen

